Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Inc (TSX: TLRY )

2.310 -0.010 (-0.43%)
Streaming Delayed Price Updated: 11:56 AM EDT, Sep 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tilray Inc

< Previous 1 2 Next >
Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds
Tilray Medical, a division of Canadian cannabis giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday a new scientific publication supported by Tilray Medical titled, Treatment in... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Billion-Dollar Cannabis Company Closes Acquisition Of Three US Breweries, What's Next For Tilray
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Is Not Giving Up On Cannabis, Ramps Up Its Canadian Portfolio On Heels Of Buying Four US Breweries
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Thursday the release of premium cannabis brand, BROKEN COAST's latest small batch flower strain dubbed 'Milk & Cookies'. The new strain is... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Can Sell And Distribute Medical Marijuana To German Pharmacies, Hospitals And More
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday that Aphria RX GmbH has received a trading license. The new permit would allow the Canadian cannabis giant to sell and distribute a... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Will Quintuple Its Medical Marijuana Production In Germany With New Cultivation License
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday that its Germany cannabis cultivation facility, Aphria RX GmbH, has obtained the first new cannabis cultivation license issued under... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
When Is Cannabis Giant Tilray Reporting Earnings And What Should Investors Expect?
Tilray Brands to release Q4 and full year 2024 results on July 29. Join the investor Q&A via Say Technologies. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Leaked Documents: Czech Republic Plans To Set Up Legal Recreational Cannabis Market
The Czech Republic could follow suit and like Germany legalize the recreational use of cannabis, according to leaked documents.The lawmakers in the European country seem to be looking to launch a fully... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
90% Of Medical Marijuana Patients Over 50 Are Treating Chronic Pain And Arthritis, Finds New Tilray Study
Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Tuesday its new scientific publication titled, Medical Cannabis for Patients Over Age 50: A Multi-Site,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Products To Try This Summer, Here's What Tilray Has In Store
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Wednesday the Good Supply launch of its 'Summer Shareability' campaign. The Canadian cannabis giant said "The brand is putting their most... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Germany Sets THC Limits For Drivers, Opposition Groups Say It's Too High
Lawmakers in Germany have set a maximum allowed limit of THC – tetrahydrocannabinol, a psychoactive substance found in the cannabis plant- for drivers to have in the blood. The Bundestag, the country's... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Ramps Up Its Cannabis Portfolio In Canada, Wins International Spirits Competition
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Thursday the launch of 'Purple Churro,' by Redecan cannabis.The new sativa offers "a sweet, indulgent experience with a potent twist and... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Launches $250M At-The-Market Program To Boost Acquisitions, Eyes Expansion With U.S. Cannabis Rescheduling
Tilray launches a $250M ATM program to fund strategic acquisitions and leverage U.S. cannabis rescheduling when effective. Read now! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Giant Tilray Reports 30% YoY Increase In Q3 Net Revenue, Updates FY 2024 Guidance
Tilray Brands reported on Tuesday financial results for its third quarter ended Feb. 29, 2024, revealing $188.3 million in net revenue, representing a 30% year-over-year increase. The Canadian medical... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows
Older patients comprise a growing subset of medical cannabis patients, according to a new study. Titled Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada, the new... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray's Redecan Launches Spring Lineup As Medical Cannabis Giant Ramps Up Its 'Diversification' Strategy
Tilray Brands (TSX: TLRY) continues to promote its cannabis vertical even though lately it's been ramping up its beer business vertical as a way to establish itself in the U.S. On Thursday, Canadian... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
The European cannabis market is one of the most rapidly expanding markets globally.Prohibition Partners revealed in its latest report on cannabis in Europe that the combined market size of all CBD... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Experts Agree On Domino Effect Of German Cannabis Legalization, Alert Companies About Rigorous Quality Control Standards & Other Challenges
Via Benzinga
Topics Cannabis
Exposures Cannabis
Huge Benefits For Medical Marijuana Patients, Opportunities For Innovation & Research – Industry Vets Weigh In On Germany's Cannabis Reform
Via Benzinga
Topics Cannabis
Exposures Cannabis
Double Your Fun With New Weed Treats From Canopy, Tilray And Cannabist
Canopy Growth Corporation has introduced five new pre-roll products across its recreational cannabis portfolio from brands 7ACRES and Hiway.In the meantime, Tilray Brands, Inc. debuted on Thursday two... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray's Diversified Growth Strategy Is Paying Off, Here's What's Behind 34% YoY Revenue Increase In Q2
Canadian cannabis company Tilray reported a 34% increase in revenue in its second quarter of fiscal 2024. The company reported revenue of $194 million, up from $145 million in the same period last... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Expands Weed Drink Selection, Here's What RIFF Brand Has In Store For Cannaseurs
Canadian cannabis company Tilray has launched two new ready-to-drink THC and CBG-infused beverages as part of its RIFF brand. The RIFF BOOST drinks are available in Tropical Burst and Vanilla Frost... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray's Chowie Wowie Launches New Weed Chocolates Just On Time For The Holidays, Here's Where To Find Them
Tilray Brands, the Canadian cannabis company, has announced the expansion of its Chowie Wowie brand with the release of two new cannabis-infused chocolates. The new flavors, Soft Caramel and Crunchy... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray's Solei Takes Tea To A New Level With Three Premium Cannabis-Infused Blends
Tilray Brands, Inc. announced on Wednesday the latest seasonal release from its cannabis wellness brand, Solei. Solei introduced three new cannabis-infused tea blends, including Decaffeinated Jasmine... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Goes Festive As Redecan's Signature Cannabis Pre-Rolls Get A Green Makeover
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced Wednesday that it's launching Redecan’s new Redees ‘Hemp’d’ pre-rolls. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Introduces New THC, CBG And CBD-Infused Beverages
Canadian weed giant Tilray Brands, Inc. (Nasdaq: TLRY) (TSX: TLRY) expanded its marijuana beverage portfolio with a range of new products from its brands XMG and Mollo. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Settles Lawsuit Relating To Bob Marley-Branded Cannabis Products Deal
A federal judge resolved and dismissed a lawsuit against Canadian cannabis giant Tilray Brands. Inc (NASDAQ: TLRY) (TSX: TLRY) in relation to a Bob Marley-branded marijuana products deal. U.S. 
Via Benzinga
Topics Cannabis Lawsuit
Exposures Cannabis Financial Legal
Tilray's Best-Selling Canadian Weed Brand Goes Green With These Eco-Friendly Solutions
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) is launching a new sustainability campaign and hemp packaging transition across its best-selling Canadian cannabis brand Good Supply. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Medical Joins Fight Against Deadly Brain Tumors, Here's What's Happening
On Monday, Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY), announced its contribution to an independent clinical trial to research the efficacy of medical cannabis as a... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Brands Q1 Cannabis Revenue Increases 9% QoQ, Narrows Net Loss
Canadian marijuana giant Tilray Brands (NASDAQ: TLRY) (TSX:TLRY), reported its financial results on Wednesday for its first quarter of fiscal year 2024 ended August 31, 2023. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Ramps Up Innovation With New Flower Offerings & Infused Pre-Roll Lineup, Here's Where To Find Them
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Friday the launch of an expanded product lineup by its quintessentially Canadian cannabis lifestyle brand, CANACA. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.